The bispecific antibodies market is poised for significant growth, specifically in the areas of cancer, autoimmune, and inflammatory therapies. This
Category: Bispecific Antibodies
BioMed X und Servier gründen erstes Forschungsteam in Frankreich zur Pionierarbeit in der KI-gesteuerten Antikörperentwicklung
BioMed X, ein führendes Innovationszentrum für die Pharmaindustrie, hat offiziell sein erstes Forschungsteam in Frankreich ins Leben gerufen. Damit wird
Accelerating Bispecific Antibody Development: Quality Insights and Strategies
The landscape of bispecific antibodies (BsAbs) is evolving rapidly, driven by increasing regulatory approvals and substantial industry investments. The